The constitutive activation of NF-κB promotes the more invasive phenotype of ER-negative cancer cells via induction of anti-apoptotic and pro-metastatic genes, such as Bcl-2 and granulocyte macrophage-colony stimulating factor (GM-CSF) [34], [35]. The gene discussed is NFKB1; the disease is cancer.